Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Nouveau launches new vitamins A&D supplement
Based on the health concerns for Baby Boomers and aging adults,Vitamins A&D is used for promoting strong bones and healthy eyes. In general, Vitamin A is used for
Based on the health concerns for Baby Boomers and aging adults,Vitamins A&D is used for promoting strong bones and healthy eyes. In general, Vitamin A is used for
Patients who have not been previously treated with a direct ALK inhibitor, such as crizotinib, are being enrolled for both trials. In the first trial, CHIARA trial (CHaperone
The OX1 patent relates to a new salt form found to be useful to increase the purity of the compound during manufacture. The company has also received a
The patent covers palifosfamide compositions, formulations, methods of use and methods of manufacture, which now includes issued patents in the US, Australia, Europe, New Zealand and South Africa.
The new US based company has entered into development, licensing and manufacturing agreements with ProMetic. Under the agreements, ProMetic has granted NantPro rights to its Plasma Protein Purification
A single administration of NX-1207 2.5mg has produced on average improvements in the standardised BPH symptom score (8-10 points at 90 days) that were approximately double that reported
The collaboration will focus on the discovery and advancement of compounds shown to block viral capsid assembly using Prosetta’s proprietary drug discovery platform. Under the agreement, Bristol-Myers will
The [123I]-E-IACFT Injection (CFT) is an Iodine-123 radiolabeled imaging agent being developed as an aid in the diagnosis of Parkinson’s disease and other movement disorders, with a potential
The patent entitled Small Volume Oral Transmucosal Dosage Forms Containing Sufentanil for Treatment of Pain claims a dosage form for oral transmucosal administration of sufentanil. The patent entitled
Budesonide Inhalation Suspension is the generic equivalent to AstraZeneca’s Pulmicort RESPULES, a maintenance medicine used to control and prevent asthma symptoms in children ages 12 months to eight